Traynor Capital Management »

Nervgen Pharma Ord shares owned by Traynor Capital Management

Quarter-by-quarter ownership of Nervgen Pharma Ord (NGENF) shares owned by Traynor Capital Management from 13F filings

Historical chart of Traynor Capital Management investment in Nervgen Pharma Ord

Tip: Access up to 7 years of quarterly data

All positions including Nervgen Pharma Ord held by Traynor Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nervgen Pharma Ord by Traynor Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $95k 26k 3.73

More positions owned by Traynor Capital Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Netflix (NFLX)
J P Morgan Exchange Traded F Equity Premium (JEPI)
Broadcom (AVGO)
Eli Lilly & Co. (LLY)
Direxion Shares Etf Trust Daily Semiconduc (SOXL)
Intuitive Surgical Com New (ISRG)
Microsoft Corporation (MSFT)
Regeneron Pharmaceuticals (REGN)
Crowdstrike Hldgs Cl A (CRWD)
Direxion Shares Etf Trust Daily Aerospace Call Option (DFEN)
J P Morgan Exchange Traded F Nasdaq Eqt Prem (JEPQ)

View all positions for Traynor Capital Management

Top funds holding Nervgen Pharma Ord

PFG Investments
Bank of America Corporation
Marshall Wace
Royal Bank of Canada
Integrated Wealth Concepts
Valley Forge Investment Consultants Inc Adv
Bank Of Montreal
Captrust Financial Advisors
UBS Group
Advisor Group Holdings
Patriot Financial Group Insurance Agency
Commonwealth Equity Services
Cetera Investment Advisers
McKinley Carter Wealth Services
Traynor Capital Management

View all funds holding Nervgen Pharma Ord